Sandhoff Disease: General Information
Author: Disabled World - Contact Details
Published: 2009/04/05 - Updated: 2023/02/01
Peer-Reviewed: N/A
On This Page: Summary - Main Article - About/Author
Synopsis: Sandhoff disease is a rare genetic lipid storage disorder resulting in the progressive deterioration of the central nervous system. Sandhoff disease is caused by a mutation (defect) in the HEXB gene. This defect causes a deficiency of the enzyme beta-hexosaminidase, which results in the accumulation of certain fats (lipids) in the brain and other organs of the body.
advertisement
Main Digest
Sandhoff Disease Alternate Names: Gangliosidosis GM2 type II, Gangliosidosis Beta Hexosaminidase B Deficiency, Hexosaminidases A and B Deficiency.
The U.S. Social Security Administration (SSA) has included Sandhoff Disease as a Compassionate Allowance to expedite a disability claim.
Sandhoff disease is caused by a mutation (defect) in the HEXB gene. This defect causes a deficiency of the enzyme beta-hexosaminidase, which results in the accumulation of certain fats (lipids) in the brain and other organs of the body.
Infantile Form
Onset of the disorder usually occurs at six months of age. Infants with Sandhoff disease typically appear normal until 3 to 6 months, when development slows and muscles used for movement weaken. Sandhoff disease symptoms may include:
- Motor weakness
- Startle reaction to sound
- Early blindness
- Progressive mental and motor deterioration
- Macrocephaly (an abnormally enlarged head)
- Cherry-red spots in the eyes
- Seizures
- Myoclonus (shock-like contractions of a muscle)
- Frequent respiratory infections
- Doll-like facial appearance
- An enlarged liver and spleen
Onset by six months of age and positive gene testing confirm the diagnosis of this disease. Individuals and carriers of Sandhoff disease can be identified by a simple blood enzyme analysis test that measures HEXB activity.
Treatment
There is no specific treatment for Sandhoff disease.
Supportive treatment includes proper nutrition, hydration, and keeping the airway open. Anticonvulsants may initially control seizures. In other ongoing studies, many children have received experimental treatment using stem cell transplants from umbilical cord blood. Although these limited trials have not yet produced a treatment or cure, scientists continue to study these and other investigational approaches.
Prognosis
The prognosis for individuals with Sandhoff disease is poor. In the Infantile form, affected children usually do not survive past age 3, and respiratory infections generally cause death.
advertisement
Discover Related Topics ▶ Page Information, Citing and Disclaimer Disabled World is an independent disability community founded in 2004 to provide disability news and information to people with disabilities, seniors, their family and/or carers. See our homepage for informative reviews, exclusive stories and how-tos. You can connect with us on social media such as X.com and our Facebook page. Permalink: <a href="https://www.disabled-world.com/health/pediatric/sandhoff-disease.php">Sandhoff Disease: General Information</a> Cite This Page (APA): Disabled World. (2009, April 5). Sandhoff Disease: General Information. Disabled World. Retrieved November 30, 2023 from www.disabled-world.com/health/pediatric/sandhoff-disease.php
Share This Information To:
𝕏.com Facebook Reddit
Disabled World provides general information only. Materials presented are never meant to substitute for qualified professional medical care. Any 3rd party offering or advertising does not constitute an endorsement.